Login

Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings 00:10:00

Share On Facebook Share On Twitter

Phil Wieland is the CEO of Diversey Holdings

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Gold Investment and the Al Fariq Project: Insights from Chuck Fipke and Chad Dolansky
00:10:00
Generative AI Truly Reshaping Business|Danel Dayan,Venture Capital Investor,Battery Ventures
00:10:00
Ciena CEO Gary Smith delivers a keynote at PTC'18 on embracing change and disruption as industry standards and transformative agents.
00:10:00
Resilience Amid Turmoil, Seizing New Horizons | Eu Chin Fen , CEO, Frasers Hospitality Trust.
00:00:00
How dermatology company is improving the lives of patients suffering from skin diseases- Matt Callahan Executive Director, Botanix Pharmaceuticals Ltd
00:10:00
Perion Network (PERI) CEO Tal Jacobson discusses digital advertising strategies with Nicole Petallides.
00:10:00
RS Minerals Announces Key Soil Results and New License Acquisition in Kazakhstan
00:10:00
CEO Spotlight: Leadership Insights from Jason C. Foster of Ori Biotech | JASON C. FOSTER , CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR OF ORI BIOTECH
00:10:00
Polaris CEO Mike Speetzen discusses their new online marketplace for powersports vehicles on 'Closing Bell: Overtime'.|Jae-Ho Kim is Director & Head-Management Support at Polaris Office Corp.
00:10:00
MINTO Apartment REIT Rings Opening Bell at Toronto Stock Exchange
00:10:00
Clayton Allen, SVP at Height Capital Markets, discusses trade policy and geopolitical risks on "Worldwide Exchange."
00:10:00
Impact of MiFID II on Market Transparency and Trading Shifts Analyzed

© 2017 - Neuhu+